Clinical Trial Update: Self Titration With Apidra to Reach Target Study (START) [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating self-titration of Apidra (insulin glulisine) to reach a target dose in adults with Type 2 diabetes mellitus; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Apidra (insulin glulisine)

Snippet

Sponsor: Sanofi | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED